BioSante Pharmaceuticals Inc. (BPAX) Stock Quote

Detailed Quote for BioSante Pharmaceuticals Inc. (BPAX) 
$ 0.851   -0.0441 (-4.93%) Volume: 7 m 4:00 PM EST Feb 10, 2012
After Hours:  $ 0.87   0.019 (+2.23%) Volume: 41.03 k 7:02 PM EST Feb 10, 2012
Today 5d 1m 3m 1y more
Last Price
0.851
Change $
0.0441
Change %
4.93%
Tick
N/A
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
0.89
High
0.91
Low
0.85
Prev Close
0.8951
Last Trade
2/10/12
Volume
7 m
52 Wk Hi
4.02
52 Wk Low
0.38
Market Cap
93.62 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
110,009,815
EPS (TTM)
-0.67
PE Ratio
N/A
Exchange
NSD
News and Media for BioSante Pharmaceuticals Inc.  (BPAX) 
Sector News | Topic News
News for BPAX
Thu, Feb 09, 2012
9:00 PM Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc. - PR Newswire
7:55 AM BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review for Phase III Program - Business Wire
Wed, Feb 08, 2012
11:15 AM BioSante Exchanges $5 Million Aggregate Principal Amount of Convertible Senior Notes for 6.7 Million Shares of Common Stock - Business Wire
Tue, Feb 07, 2012
6:47 PM Investor Alert: Kahn Swick & Foti, LLC and Partner Former Louisiana Attorney General Remind Investors With Large Financial Interests of Lead Plaintiff Deadline in Lawsuit Against BioSante Pharmaceuticals, Inc. - Business Wire
11:37 AM Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) - Marketwire
9:00 AM Perception, Opportunity in Volatility - Research & Analysis on Dendreon Corporation and BioSante Pharmaceuticals, Inc. - Marketwire
Mon, Feb 06, 2012
9:05 AM Robbins Umeda LLP Announces Class Action Suit Against BioSante Pharmaceuticals, Inc. - Business Wire
Tue, Jan 31, 2012
8:20 AM Shares of BioSante and Cell Therapeutics on the Upswing as Biotech Sector Rallies - Marketwire
7:55 AM BioSante Pharmaceuticals Provides Corporate Update - Business Wire
Tue, Jan 17, 2012
8:20 AM Biotechnology Industry on the Upswing - BioSante and Cardium Therapeutics Look to Rally - Marketwire
Wed, Jan 11, 2012
6:20 PM The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Securities Laws Violations by BioSante Pharmaceuticals, Inc. - Business Wire
6:30 AM Robbins Umeda LLP Announces an Investigation of BioSante Pharmaceuticals, Inc. - Business Wire
Thu, Jan 05, 2012
8:16 AM Battered Down Shares of Cell Therapeutics and BioSante Look to Rebound in 2012 - Marketwire
Wed, Dec 14, 2011
4:06 PM BioSante Pharmaceuticals Announces Results from LibiGel® Efficacy Trials - Business Wire
Thu, Dec 01, 2011
8:16 AM Drug Candidates From Alexza and BioSante Pharmaceuticals Inch Closer to Decision Day - Marketwire
7:00 AM Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinson's Disease - PR Newswire
Tue, Nov 29, 2011
9:00 AM BioSante Pharmaceuticals Announces Issuance of New LibiGel® Method of Use Patent - Business Wire
Mon, Nov 21, 2011
7:55 AM BioSante Pharmaceuticals Added to NASDAQ Biotechnology Index - Business Wire
Thu, Nov 17, 2011
8:16 AM Cheap Valuations for Dendreon and BioSante Spark Investor Interest - Marketwire
Wed, Nov 16, 2011
7:55 AM BioSante Pharmaceuticals Announces Positive LibiGel® Pharmacokinetic Study Results - Business Wire
More News for BPAX >>

Tags for BioSante Pharmaceuticals Inc.

Research stocks or mutual funds related to BioSante Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to BPAX. The keywords below have been associated to BPAX by either user submission or electronic means.

herbal menopause dhea hormone symptoms of menopause testosterone menopause increase libido female menopause know menopause women's libido pharmaceuticals companies thyroid hormone replacement decreased libido women women libido dupont pharmaceuticals decreased libido Biological Products estrogen replacement therapy womens libido woman libido human growth hormone pharma license libido sexuality female progesterone cream drug delivery women menopause pharmaceutical sales hormones aphrodisiacs for women testosterone patch menopause hormone replacement therapy no libido pharma Testosterone replacement therapy pharmaceutical development loss of libido pharmaceutical reports pharmaceutical magazine hormones female Drugs women testosterone natural hrt testosterone women low female enhancement bioidentical hormone replacement therapy menopause treatment female libido drug testosterone female low elan pharmaceutical pharmaceutical sale menopause relief

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.